Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
JAMA
|
September 25, 1981
Deep venous thrombosis and pulmonary embolism. Frequency in a respiratory intensive care unit
K M Moser, J R LeMoine, F J Nachtwey, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 1, 1996
Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant
A Ahuja, N Oh, W Chao, et al.
The Journal of Clinical Investigation
|
March 1, 1982
Studies on the pathogenesis of the adult respiratory distress syndrome
W W McGuire, R G Spragg, A B Cohen, et al.
Analytical Biochemistry
|
March 2, 1991
Radiolabeling of the hydrophobic components of lung surfactant with 3-(trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine
N Gilliard, D Pappert, T A Merritt, et al.
The Journal of Clinical Investigation
|
October 1, 1989
Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep
R M Smith, L D Traber, D L Traber, et al.
The American Journal of Medicine
|
June 24, 1988
Intravenous administration of alpha-1-proteinase inhibitor in patients of PiZ and PiM phenotype. Preliminary report
K M Moser, R M Smith, R G Spragg, et al.
The European Respiratory Journal. Supplement
|
March 1, 1989
The adult respiratory distress syndrome: first trials with surfactant replacement
P S Richman, R G Spragg, B Robertson, et al.
The American Journal of Medicine
|
June 1, 1983
Angiosarcoma of the lung with fatal pulmonary hemorrhage
R G Spragg, P L Wolf, P Haghighi, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
February 5, 2000
Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury
R G Spragg, R M Smith, K Harris, et al.
The American Review of Respiratory Disease
|
December 1, 1987
Pulmonary penetration of alpha 1-proteinase inhibitor administered parenterally to dogs
R M Smith, R G Spragg, K M Moser, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
JAMA
|
September 25, 1981
Deep venous thrombosis and pulmonary embolism. Frequency in a respiratory intensive care unit
K M Moser, J R LeMoine, F J Nachtwey, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 1, 1996
Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant
A Ahuja, N Oh, W Chao, et al.
The Journal of Clinical Investigation
|
March 1, 1982
Studies on the pathogenesis of the adult respiratory distress syndrome
W W McGuire, R G Spragg, A B Cohen, et al.
Analytical Biochemistry
|
March 2, 1991
Radiolabeling of the hydrophobic components of lung surfactant with 3-(trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine
N Gilliard, D Pappert, T A Merritt, et al.
The Journal of Clinical Investigation
|
October 1, 1989
Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep
R M Smith, L D Traber, D L Traber, et al.
The American Journal of Medicine
|
June 24, 1988
Intravenous administration of alpha-1-proteinase inhibitor in patients of PiZ and PiM phenotype. Preliminary report
K M Moser, R M Smith, R G Spragg, et al.
The European Respiratory Journal. Supplement
|
March 1, 1989
The adult respiratory distress syndrome: first trials with surfactant replacement
P S Richman, R G Spragg, B Robertson, et al.
The American Journal of Medicine
|
June 1, 1983
Angiosarcoma of the lung with fatal pulmonary hemorrhage
R G Spragg, P L Wolf, P Haghighi, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
February 5, 2000
Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury
R G Spragg, R M Smith, K Harris, et al.
The American Review of Respiratory Disease
|
December 1, 1987
Pulmonary penetration of alpha 1-proteinase inhibitor administered parenterally to dogs
R M Smith, R G Spragg, K M Moser, et al.
Page
of 6